Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
NCT05779865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2023-09-25
Summary
Lesions blurred by respiratory motion are common in fluorine-18 PET/CT studies. To avoid these artefacts, several standard gating correction technics are available. the investigator aimed to compare the impact of different gating techniques based on phase, amplitude, elastic-motion monitored with and without pressurre sensor device on standardized uptake value (SUVmax and SUVpeak) and uptake volume (UV) measurements on different sizes of pulmonary and liver lesions. The feasability of this study will be done using anthropomorphic coupled with a motion phantom and on a series of patients.
Conditions
- Lung; Nodule
- Liver Metastases
Sponsors & Collaborators
-
Centre Hospitalier Princesse Grace
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-15
- Primary Completion
- 2023-06-01
- Completion
- 2023-09-21
Countries
- Monaco
Study Locations
More Related Trials
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Follow-up of Patients With Curative-intent Surgical Resection for NSCLC
NCT00199615 ·Status: COMPLETED ·Phase: NA
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
FDG PET-CT in Advanced Breast Cancer
NCT07173868 ·Status: RECRUITING
-
To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
NCT01888692 ·Status: TERMINATED
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
68Ga-DOTA-TATE PET/CT Imaging in NETs
NCT04847505 ·Status: RECRUITING ·Phase: PHASE3
-
PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells
NCT05176275 ·Status: UNKNOWN ·Phase: NA
-
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
NCT04804371 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN
-
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
NCT05537675 ·Status: COMPLETED
-
Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer
NCT02821936 ·Status: COMPLETED ·Phase: NA
-
Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating
NCT00843219 ·Status: COMPLETED
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity
NCT07302763 ·Status: RECRUITING ·Phase: NA
-
68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study
NCT05228106 ·Status: RECRUITING
-
Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
NCT02317393 ·Status: COMPLETED ·Phase: PHASE2
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 ·Status: RECRUITING
-
Modeling of the Response to Hypofractionated Stereotactic Pulmonary Irradiation
NCT03175861 ·Status: UNKNOWN
-
Prognostic PET/CT Model in Non Small Cell Lung Cancer
NCT03199599 ·Status: COMPLETED
-
Wholebody MRI In Lung Cancer StagiNg
NCT02716051 ·Status: COMPLETED ·Phase: NA
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1